IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Global Blood Therapeutics in

Q2 2022 vs Q3 2022

Comparing institutional holders between quarters

Quarters

Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Maven Securities LTD
NEW
Shares255,800
Change+255,800
Value$17.4K
Filed 2022-11-16
Status
Maven Securities LTD
NEW255,800—+255,800——$17.4K—2022-11-16
Showing 1 of 1 institutions